Sign in

CIK 0001841387 · <br>Emerging growth company

Candel Therapeutics, Inc.

Sign in to watch
Ticker
CADL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522214851
Phone
617-916-5445
Business address
117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
  1. ARS Other Annual Report to Security Holders
  2. DEFA14A Proxy Proxy Materials
  3. DEF 14A Proxy Proxy Statement
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. SCHEDULE 13D/A Stake Beneficial Ownership Report
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 10-K Report Annual Report
  11. 8-K Event Results of operations
  12. 4 Open-market buy Director bought 550,458 shares at $5.45 ($2,999,996)
  13. 8-K Event Material agreement · Other events
  14. 424B5 Offering Prospectus
  15. 424B5 Offering Prospectus
  16. 8-K Event Material agreement · Results of operations · Regulation FD disclosure · Other events
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 21 · 418 filings